Corrections or additions?
Published in U.S. 1 Newspaper on June 7, 2000. All rights reserved.
Tachyon Zooms In On Nasdaq
Wall Street was waiting for this, a smarter way to trade
stocks on the Nasdaq market. The launch of Tachyon Systems’ first
product, FalconEye, was Thursday, June 1.
"This is an unprecedented effort to deliver real time data and
analytics over the Internet through Java applets," says Keith
Danko, co-founder of Tachyon Systems with Sasha Migdal, the Russian-born
scientist also responsible for the technology behind Real Time Geometry,
aka Metastream (U.S. 1 April 19). "To our knowledge nothing like
this has ever been done before."
Based on Hulfish Street, Tachyon is creating a new paradigm, Danko
claims. "It is not the next anything. It is part of what I think
will be a new model for Internet businesses, not built around selling
you something over the Internet." Tachyon is built around giving
the traders a useful method to analyze the kind of information that
the Internet makes possible, and communicating the resulting content
in a very convenient fashion.
The FalconEye uses Level 2 information from the Nasdaq market. Danko
says that FalconEye will include three levels of service. "The
novice level will be free and offer limited examples of our features.
The Plus+ level will be $34.95 per month, and the Pro level is $99.95
per month with discounts available for annual subscriptions to each."
FalconEye services include:
of the entire Nasdaq market. It resembles the clouds of a weather
map, because it expands and contracts, using Java technology. "It
allows investors to discover interesting stock trading opportunities
that they may not have discovered by any other means," says Danko.
"They can use it to get ideas."
technical indicators. "It plots the entire market and ranks each
stock according to the indicators." It looks at density, finding
which stocks are least like the other stocks in that particular plot,
and which are most unique on that plot. "If they are unique, something
is going on with them," says Danko. "Something is happening,
relative to the market and what you have plotted, though at this point
you won’t know what it is. So you click on that stock to see if there
is something interesting."
"This appeals to the person who wants to get ideas that maybe
nobody else is looking at," says Danko. He thinks the possibilities
are endless. "There will be users who will be the ones to teach
how to use that product."
with a menu of 120 technical indicators to choose from. This is the
first time traders have been able to watch the indicators work in
real time for the Nasdaq Level 2 market, says Danko.
says Danko, that provides statistical guidance that investors can
use before they place stock orders. This Tachyon tool uses proprietary
analytics to give statistical information on estimated chances of
doing well on the bid/offer spread, buying at a low bid price and
selling at a high offered price.
do," says Danko. "Our goal is to be a cutting edge creator
of real time analytics. We chose the Nasdaq Level 2 area first because
no one had been able to do it, and we thought it would gain notoriety
for us quickly."
08540. Keith Danko, CEO. 609-921-2216. Www.tachyonsystems.com.
More news about Nassau Broadcasting’s initial public
offering: The S-1 filing on May 9 stated that Nassau Broadcasting
hoped to offer shares of Class A stock worth $190 million, says Judy
Brenna, the company’s new director of corporate communications and
investor relations (formerly with Integra Life Sciences and Noonan
Russo). The exact number or price of the shares has not been determined.
The funds would be used to finance acquisitions as well as to pay
off debt. Including the stations it is now in the process of buying,
Nassau operates 17 FM and 15 AM stations. These stations represent
nine markets in New Jersey, Pennsylvania, New York, and Connecticut.
For 1999 the net revenues were $31.4 million and broadcast cash flow
was $10.6 million.
Shares would be listed on Nasdaq as NBCR.
Road, Box 1350, Princeton 08540. Louis F. Mercatanti Jr., CEO. 609-419-0300;
fax, 609-419-0143. Home page: www.nbplp.com.
3400, Princeton 08540. David Stehlin, CEO. 609-514-1800; fax, 609-514-1881.
Home page: www.onepath.com.
When David Stehlin opened this office as Foxcom last year, it was
a privately-held Israeli company that designed, manufactured and marketed
broadband fiberoptic transmission systems. Its fiberoptic transmitters
and receivers could deliver up to 2 GHz of bandwidth to users (U.S.
1, August 11, 1999). Now Stehlin has changed its name to Onepath Networks
to reflect the change in strategy. "Last year our products were
pure video," says Stehlin. "Now we make transmission equipment
for video, data, and voice." To DualStar, Hughes, Pan Am Sat,
Southwest Bell, British Telecom, Hyundai, Samsung, and Singapore Telecom,
he has added such clients as Bell Atlantic. The staff in Princeton
has grown to "the mid 20s" and will be up to 40 by the end
of the year. The 90 workers in Israel are expected to grow to 120.
A graduate of the Naval Academy, Class of 1979, Stehlin spent five
years as an officer in the Marine Corps, traveling around the world,
before joining a North Carolina fiber optics company. During his nine
years at Keptel in Tinton, New Jersey, Stehlin dramatically increased
the company’s revenues.
600 College Road East, Princeton 08540. Tom Evslin, CEO. 609-419-1500;
fax, 609-419-1511. Home page: www.itxc.com.
Intel Corporation will license its Internet telephony software technology
to ITXC for the College Road-based firm to use in its webtalkNOW!
Service. "Intel’s technology improves the quality of voice communication
when making a call from a PC to a phone, achieving nearly the same
quality as when making a phone to phone call," says a press release.
ITXC combines Intel’s telephony software with its own patent-pending
voice traffic management technology, called BestValue Routing, to
deliver carrier-grade voice quality over the Internet to Web-based
08540. James Cunningham, president, northeast region. 609-514-3800;
fax, 609-514-9010. Home page: www.newjersey.verio.net.
The international Internet service provider has been bought by ATT
Japan for $5 billion. This ISP started out in academe as JvNCnet,
was taken private as Global Enterprise Services, and was sold to the
Colorado-based Verio. It offers a full range of Internet connections,
corporate private virtual networks, training, managed security services,
interactive media for the World Wide Web, and consulting
Suite 110, Trenton 08691-3307. Ron Keppel, president. 609-584-7790;
fax, 609-584-7723. Home page: www.vandalproof.com.
The eight-year-old supplier of emergency telephones has been sold
for $900,000 to Halma, a British company based in Amersham in Buckinghamshire.
For the present, at least, 15 people will remain on Crossroad Drive.
Its clients include the Port Authority of New York/New Jersey, the
Baltimore Mass Transit Association, and Amtrak for the Hudson River
Tunnel, where the steel-encased phones are used by train personnel
for emergencies and maintenance purposes. Another product is a telephone
East, Box 2197, Princeton 08540-2197. Dale R. Pfost, CEO. 609-750-2200;
fax, 609-750-2250. Home page: www.orchid.com.
Orchid Biosciences Inc. will commercialize an open-platform system
developed by Luminex Corporation and add it to Orchid’s line of instruments
that conduct single nucleotide polymorphism (SNP) scoring. A public
company (LMNX) based in Austin, Texas, Luminex has a LabMAP system
that performs up to 100 assays simultaneously on a single drop of
fluid. Its technology employs low-cost microsphere-based assays with
small lasers, advanced digital signal processors, and proprietary
software. Its collaboration with Orchid will target laboratories performing
assays at medium speed.
Suite 206, Princeton 08540. Donald L. Drakeman, president. 609-430-2880;
fax, 609-430-2850. Home page: www.medarex.com.
Medarex is joining Biosite Diagnostics in using Trans-Phage technology
to speedily make large volumes of fully human antibodies for virtually
any disease target. For this, Medarex would use its special HuMAb-Mouse
and Biosite would contribute Omniclonal phage display technology.
Medarex will pay $3 million a year for eight years to Biosite’s research
fund. Biosite’s products are used in nearly half of U.S. hospitals
Drive, Suite 202, Monmouth Junction 08852. Martyn Greenacre, CEO.
732-329-3407; fax, 609-520-6692. Home page: www.delsyspharma.com.
Delsys Pharmaceutical Corporation was granted three patents by the
U.S. Patent and Trademark office. One covers automated systems for
manufacturing solid oral dosage forms using the company’s proprietary
Accudep technology, which enables dry pharmaceutical powders to be
electrostatically deposited onto a variety of substrates. The other
patents relate to new applications of this technology to manufacture
diagnostic products. Delsys now holds 14 issued patents of its Accudep
engineer for RCA and General Electric.
at Princeton University.
president of PrinVest on Princess Road.
at St. Francis Medical Center. A mass of Christian Burial will be
Thursday, June 8, at 11 a.m. at St. Ann’s Church in Lawrence.
Corrections or additions?
This page is published by PrincetonInfo.com
— the web site for U.S. 1 Newspaper in Princeton, New Jersey.